Back to top
more

CVS Health (CVS)

(Delayed Data from NYSE)

$56.12 USD

56.12
9,720,672

-0.82 (-1.44%)

Updated Sep 11, 2024 03:59 PM ET

After-Market: $56.12 0.00 (0.00%) 4:18 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 6% (234 out of 250)

Industry: Retail - Pharmacies and Drug Stores

Better trading starts here.

Zacks News

Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.

Zacks Value Trader Highlights: AbbVie, Allergan, Occidental, Chevron and CVS

Zacks Value Trader Highlights: AbbVie, Allergan, Occidental, Chevron and CVS

Tracey Ryniec headshot

One of Your Stock Investments is Being Acquired: Now What?

One of your companies gets a buyout offer and the shares soar. There might be different strategies for traders and investors on what to do next.

What's in Store for SmileDirectClub's (SDC) Q4 Earnings?

SmileDirectClub (SDC) is likely to have gained from a strong international presence in Q4.

Sheraz Mian headshot

Top Stock Analyst Reports for Apple, American Express & Starbucks

Today's Research Daily features new research reports on 16 major stocks, including Apple (AAPL), American Express (AXP) and Starbucks (SBUX).

Know These 3 Facts to Avoid Paying Half Your Retirement Income to the IRS - February 13, 2020

Like the majority of investors, you're most likely working on a retirement portfolio that will provide a large enough nest egg to give you a comfortable retirement. Make sure you know all about what financial planners call the accumulation and distribution phases of retirement planning.

The Federal Budget in Focus

The Federal Budget in Focus

CVS Health (CVS) Q4 Earnings Top Estimates, Margins Improve

CVS Health (CVS) registers strong growth in Pharmacy Services, benefiting from the upside in specialty services.

Mark Vickery headshot

Shopify, CVS Outperform in Q4, Plus COVID-19 Update

Shopify (SHOP) impressed investors with a big beat on both top and bottom lines: 43 cents per share versus 23 cents expected, on $505.2 million which easily surpassed the Zacks consensus $482.3 million.

Can Pharmacy Services Growth Aid CVS Health (CVS) Q4 Earnings?

Expanded claims volume and better purchasing economics are expected to have aided CVS Health's (CVS) top line in Q4.

CVS Health (CVS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CVS Health (CVS) Gains But Lags Market: What You Should Know

In the latest trading session, CVS Health (CVS) closed at $67.88, marking a +1.42% move from the previous day.

Urmimala Biswas headshot

Pharmacies & Drug Stores Industry Outlook: Prospects Mixed

The Retail - Pharmacies and Drug Stores industry is known for heavy consolidations.

CVS Health (CVS) Dips More Than Broader Markets: What You Should Know

In the latest trading session, CVS Health (CVS) closed at $70.55, marking a -1.77% move from the previous day.

CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know

CVS Health (CVS) closed at $73.53 in the latest trading session, marking a -0.65% move from the prior day.

Why CVS Health (CVS) Could Beat Earnings Estimates Again

CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

The Zacks Analyst Blog Highlights: UnitedHealth, CVS Health, Morgan Stanley, Charles Schwab and Uber Technologies

The Zacks Analyst Blog Highlights: UnitedHealth, CVS Health, Morgan Stanley, Charles Schwab and Uber Technologies

CVS Health's Selling Seasons Strong, Omnicare Arm Upsets

CVS Health's (CVS) 2020 PBM selling season remains strong with gross new business and net new business wins.

CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, CVS Health (CVS) closed at $72.76, marking a +0.9% move from the previous day.

Sheraz Mian headshot

Top Research Reports for UnitedHealth, CVS & Morgan Stanley

Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group (UNH), CVS Health (CVS) and Morgan Stanley (MS).

CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know

CVS Health (CVS) closed the most recent trading day at $73.86, moving +0.39% from the previous trading session.

CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, CVS Health (CVS) closed at $74.29, marking a +0.8% move from the previous day.

CVS Health (CVS) Gains As Market Dips: What You Should Know

In the latest trading session, CVS Health (CVS) closed at $74.51, marking a +0.17% move from the previous day.

Rite Aid (RAD) Earnings Surpass Estimates in Q3, Stock Up

Rite Aid (RAD) posts robust results in third-quarter fiscal 2020. Notably, the bottom line benefits from higher adjusted EBITDA in the quarter.

Walgreens is the Worst Dow Stock Now, Will 2020 Be Different?

Despite the dismal performance in recent times, Walgreens (WBA) has chances to bounce back in 2020.

Sapna Bagaria headshot

HMO Industry Outlook: Multiple Levers to Drive Growth

Aging U.S population, consolidation, use of technology and growing health service businesses provide ample scope for the industry to grow.